Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation

Fig. 1

ANGPTL4 expression is highest in A2780 and CAOV3 ovarian cancer cells and tumors. a Western blot and statistical graph of angiopoietin-like 4 (ANGPTL4) expression in human ovarian clear cell carcinoma ES2 cells, human ovarian carcinoma A2780 and NCI/ADR-RES cells, and human ovarian adenocarcinoma COC1, SKOV3, OVCAR3, and CAOV3 cells; n = 3 independent experiments per group. b qRT-PCR analysis was performed to determine the expression pattern of ANGPTL4 mRNA in human ovarian cancer cells; n = 3 independent experiments per group. c Immunofluorescence analysis and statistical graph of ANGPTL4 expression in ovarian cancer cells; n = 3 per group. Scale bar: 50 μm. d Western blot and statistical graph of ANGPTL4 expression in the A2780 and CAOV3 xenograft models; n = 4 independent experiments per group. e qRT-PCR analysis of ANGPTL4 mRNA expression was also carried out in A2780 and CAOV3 tumors; n = 4 independent experiments per group. ***p < 0.001 for the indicated comparisons. The data are presented as the mean ± SEM values

Back to article page
\